Back to results
US 6,787,320 B2Granted
In vitro methods for determining in vivo thrombotic events
AssigneeThe Scripps Research Institute
InventorsMark H. Ginsberg, Andrew L. Frelinger, III, Edward F. Plow
Life of this patent
Estimating the term…
Abstract
Diagnostic systems, methods, polypeptides and antibodies for detecting the presence of C-terminal hGPIIb fragment of the platelet receptor GPIIb-IIIa in a body fluid sample are disclosed.
Claims18
A method of detecting a C-terminal heavy chain platelet glycoprotein receptor (hGPIIb) polypeptide in a body fluid sample, comprising the steps of:
- a. admixing an aliquot of the body fluid sample with a composition including an antibody to form an immunoreaction admixture, wherein the antibody:
- i. immunoreacts with the C-terminal hGPIIb polypeptide including an amino acid sequence of PQPPVNPLKVDWGLPIPSPSP (SEQ ID NO:3 from residue 173 to residue 193), PQPPVNPLK (SEQ ID NO:3 from residue 173 to residue 181), PLKVDWGLPIP (SEQ ID NO:3 from residue 179 to residue 189), PIPSPSPIHPAHHK (SEQ ID NO:3 from residue 187 to residue 200), or IHPAHHK (SEQ ID NO:3 from residue 194 to residue 200), and
- ii. does not specifically immunoreact with an amino acid sequence represented by the formula REQNSLDSWGPK (SEQ ID NO:3 from residue 113 to residue 124);
- b. maintaining the immunoreaction admixture under biological assay conditions for a time period sufficient to form an immunoreaction product;
- and
- c. detecting the immunoreaction product, and thereby the C-terminal hGPIIb polypeptide.
3 more elements
Dependencies are inferred from the claim text.